WAUWATOSA, WIS. - GE Healthcare, the $17 billion business unit of General Electric Company (NYSE: GE), today introduced the new Venue™ ultrasound product line to the medical market. The Venue 40, the first product launched, provides visualization for needle guidance procedures and rapid diagnostics in real-time at the bedside. These "point of care" settings are the fastest growing in ultrasound around the world. In the U.S., these applications grew an average of 30 percent per year over the past four years, as cited in a recent 2008 industry report issued by Klein Biomedical Consultants, an internationally recognized source of ultrasound market trends.
An intuitive touch screen and streamlined design make Venue 40 easy to use and easy to clean, especially for clinicians who use ultrasound to make immediate care decisions, or guide procedures.
Story Continues Below Advertisement
Care networks have had to choose between performing service in-house and outsourcing service to one or more device manufacturers. GE Healthcare in-house support programs create multiple ways for the parties to work together to achieve important outcomes
Ultrasound offers visualization for procedures that are conventionally performed through traditional landmark techniques, without imaging technology. The Venue 40 comes in five versions, designed for specific procedures and diagnostic exams:
-Venue 40 Vascular Access: Allows placement of peripheral or central lines with exceptional visualization of anatomy and needle at the bedside.
-Venue 40 Anesthesia: Increases precision and clinical confidence with clear visualization of both anatomy and needle for performing regional nerve blocks.
-Venue 40 Interventional: Visualizes biopsy guidance, line placements and rapid diagnostics at the bedside. Applications include visualizing the needle for a breast biopsy or vein ablation, as well as other minimally invasive procedures.
-Venue 40 Musculoskeletal: Helps provide accurate diagnoses and treatment for the hospital, office or training room. Clinicians could use the device to diagnose, treat and monitor a patient with rheumatoid arthritis. Other applications include diagnosing and treating muscle, tendon and joint problems in sports medicine.
-Venue 40 Point of Care: Enables rapid diagnosis and cardiac assessment in the ICU/CCU, trauma bay or bedside. The device could be used to visualize an ICU patient's heart function and anatomy, or to help identify life-threatening abnormalities or free fluid in a trauma patient in the ER.
"GE's Venue 40 ultrasound system is a major advancement," said Dr. Jeff Swenson, Professor of Anesthesiology at the University of Utah and Director of Anesthesia at the University of Utah Orthopaedic Center, Salt Lake City, Utah. "It's extremely user friendly and offers very precise images with little or no adjustment to the settings. As we increasingly use ultrasound for imaging, the Venue 40 technology will allow clinicians to image fascial planes and high resolution anatomy more safely."